Expect More Bleeding When Cangrelor Is Used

September 2015

You'll hear more about the new IV antiplatelet med, cangrelor (Kengreal, KEN-gree-el).

Think of it as similar to clopidogrel, ticagrelor, or prasugrel during percutaneous coronary intervention (PCI)...but in an IV form.

You'll hear about its immediate onset and rapid offset...but be aware of limitations.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote